<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BLRX
BioLineRx
$
()


  • BioLineRx to sell 7.5M ADSs at 80c in registered direct offering

    4/1/2024 - 09:05am
  • Biotech Alert: Searches spiking for these stocks today

    3/28/2024 - 10:59am
  • BioLineRx receives Notice of Allowance from USPTO for a patent

    3/4/2024 - 07:12am
  • Biotech Alert: Searches spiking for these stocks today

    2/28/2024 - 11:59am
  • BioLineRx announces dosing of frist patient in CheMo4METPANC Phase 2 trial

    2/28/2024 - 07:22am
  • BioLineRx files $250M mixed securities shelf

    12/29/2023 - 16:17pm
  • BioLineRx doses first patient in Phase 1 clinical trial of motixafortide

    12/21/2023 - 07:02am
  • Biotech Alert: Searches spiking for these stocks today

    11/2/2023 - 11:08am
  • BioLineRx enters license agreement with GloriaBio, investor

    10/31/2023 - 09:05am
  • BioLineRx closes exclusive license agreement with Guangzhou Gloria Biosciences

    10/12/2023 - 07:02am
  • Largest borrow rate increases among liquid names

    10/9/2023 - 08:45am
  • BioLineRx's motixafortide shows 'encouraging' efficacy in pancreatic cancer

    9/28/2023 - 07:04am
  • BioLineRx price target raised to $21 from $19 at H.C. Wainwright

    9/15/2023 - 06:08am
  • Largest borrow rate increases among liquid names

    9/14/2023 - 08:45am
  • BioLineRx announces FDA approval of APHEXDA/filgrastim combination

    9/11/2023 - 07:02am
dynamic_feed Breaking News